Overcoming asset transfer challenges during a merger and acquisition (M&A)
In this video, Parexel’s Paul Bridges speaks with Phil Smith about how pharma and biotech can overcome common operational challenges and key considerations for a more successful asset transfer.
Related Insights
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Related Insights
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022